Table 2. Steroid hormone z-scores in children from the placebo and metformin groups.
a) Children of both sexes | |||||
The maternal PCOS effecta | The metformin effectb | ||||
Placebo, n = 54 | p | Metformin, n = 63 | Δ M-P (95% CI) | p | |
Mean (95% CI) | Mean (95% CI) | ||||
Androstenedione z-score | 0.53 (0.27 to 0.79) | .0001* | 0.66 (0.41 to 0.91) | 0.13 (-0.23 to 0.49) | .470 |
Testosterone z-score | 0.53 (0.29 to 0.77) | < .0001* | 0.53 (0.30 to 0.76) | 0.00 (-0.33 to 0.33) | .995 |
SHBG z-score | -0.28 (-0.55 to 0.00) | .051 | -0.28 (-0.51 to -0.05) | 0.01 (-0.36 to 0.34) | .973 |
Cortisol z-score | 0.34 (0.08 to 0.61) | .012 | 0.69 (0.42 to 0.96) | 0.35 (-0.03 to 0.72) | .070 |
17-OH-progesterone z-score | 0.42 (0.15 to 0.69) | .003 | 0.83 (0.62 to 1.04) | 0.41 (0.08 to 0.74) | .015 |
11-deoxycortisol z-score | 0.13 (-0.11 to 0.37) | .269 | 0.46 (0.22 to 0.69) | 0.32 (-0.01 to 0.66) | .056 |
Free testosterone z-score | 0.67 (0.38 to 0.96) | < .0001* | 0.63 (0.35 to 0.91) | -0.04(-0.44 to 0.36) | .841 |
b) Boys | |||||
The maternal PCOS effecta | The metformin effectb | ||||
Placebo, n = 24 | p | Metformin, n = 31 | Δ M-P (95% CI) | p | |
Mean (95% CI) | Mean (95% CI) | ||||
Androstenedione z-score | 0.27 (-0.15 to 0.69) | .195 | 0.74 (0.45 to 1.02) | 0.46 (-0.02 to 0.95) | .058 |
Testosterone z-score | 0.25 (-0.20 to 0.70) | .264 | 0.54 (0.22 to 0.85) | 0.29 (-0.23 to 0.81) | .268 |
SHBG z-score | 0.03 (-0.45 to 0.51) | .905 | -0.43 (-0.75 to -0.11) | -0.46 (-0.99 to 0.08) | .096 |
Cortisol z-score | 0.51 (0.17 to 0.84) | .005 | 0.82 (0.37 to 1.27) | 0.31 (-0.27 to 0.89) | .284 |
17-OH-progesterone z-score | 0.40 (-0.07 to 0.87) | .089 | 0.93 (0.61 to 1.24) | 0.53 (-0.00 to 1.06) | .052 |
11-deoxycortisol z-score | 0.08 (-0.31 to 0.47) | .670 | 0.74 (0.38 to 1.09) | 0.65 (0.14 to 1.17) | .014 |
Free testosterone z-score | 0.25 (-0.23 to 0.73) | .292 | 0.67 (0.34 to 1.00) | 0.42 (-0.13 to 0.97) | .133 |
c) Girls | |||||
The maternal PCOS effecta | The metformin effectb | ||||
Placebo, n = 30 | p | Metformin, n = 32 Mean (95% CI) |
Δ M-P (95% CI) | p | |
Mean (95% CI) | |||||
Androstenedione z-score | 0.73 (0.41 to 1.06) | < .0001* | 0.59 (0.16 to 1.01) | -0.15 (-0.68 to 0.38) | .580 |
Testosterone z-score | 0.76 (0.51 to 1.00) | < .0001* | 0.53 (0.18 to 0.88) | -0.23 (-0.66 to 0.19) | .280 |
SHBG z-score | -0.51(-0.83 to-0.19) | .003 | -0.13 (-0.47 to 0.20) | 0.37 (-0.08 to 0.83) | .104 |
Cortisol z-score | 0.21 (-0.19 to 0.61) | .291 | 0.56 (0.24 to 0.89) | 0.35 (-0.15 to 0.86) | .165 |
17-OH-progesterone z-score | 0.44 (0.11 to 0.76) | .010 | 0.74 (0.44 to 1.03) | 0.30 (-0.13 to 0.73) | .162 |
11-deoxycortisol z-score | 0.18 (-0.14 to 0.49) | .291 | 0.19 (-0.11 to 0.48) | 0.01 (-0.41 to 0.44) | .952 |
Free testosterone z-score | 0.99 (0.67 to 1.32) | < .0001* | 0.59 (0.12 to 1.06) | -0.40 (-0.96 to 0.16) | .157 |
*p-values statistically significant after Holm-Bonferroni adjustment.
aThe impact of maternal PCOS on steroid hormones was assessed by the deviation in z-scores between the placebo group and the reference population (z-score zero) by one sample t-tests.
bΔ M-P expresses the metformin effect on hormone mean z-scores, assessed by two sample t-tests.
All z-scores were calculated from the Bergen Growth Study 2 references, according to gender and age.
CI: confidence interval; SHBG: sex hormone binding globulin.